1-A LIVE 0001997296 XXXXXXXX false false Medicus Pharma Ltd. A6 2008 0001997296 2834 98-1778211 12 0 300 Conshohocken State Rd., Suite 200 W. Conshohocken PA 19428 610-540-7515 Christopher J. Cummings Other 5306159.00 0.00 0.00 0.00 5720909.00 1879834.00 0.00 2228805.00 3492104.00 5720909.00 0.00 8830197.00 78395.00 -8880935.00 -0.31 -0.31 EisnerAmper LLP Common shares, no par value 11922561 58471K202 The Nasdaq Capital Market,The TSX Venture Exchange Public Warrants 1115500 58471K111 The Nasdaq Capital Market Options 1185000 N/A N/A 0 0 true true false Tier2 Audited Equity (common or preferred stock) Option, warrant or other right to acquire another security Security to be acquired upon exercise of option, warrant or other right to acquire security Y Y Y N N N 5333334 11922561 4.2500 22666670.00 0.00 0.00 0.00 22666670.00 Maxim Group LLC 1700000.00 MNP LLP 100000.00 Paul, Weiss, Rifkind, Wharton and Garrison LLP; Bennett Jones LLP 500000.00 000120708 20216669.00 Securities offered consists of 5,333,334 units, each consisting of one common share and one warrant. The issuer has 11,922,561 common shares outstanding prior to the offering. No warrants of the class being offered are outstanding prior to the offering. false true AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 false Medicus Pharma Ltd. Convertible notes 5172500 0 $5,172,500 (principal amount of convertible notes issued) Medicus Pharma Ltd. Common shares issued upon conversion of the convertible notes 1308798 0 N/A Medicus Pharma Ltd. Common Shares 2922500 0 $5,845,000. 2,922,500 common shares issued at a price of $2.00 per share. Medicus Pharma Ltd. Stock Options 505000 0 N/A These securities were sold in reliance on Regulation S promulgated under the Securities Act, Regulation D under the Securities Act, Rule 701 under the Securities Act or pursuant to Section 4(a)(2) of the Securities Act.